Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Bünde – page 30

618 clinical trials in Bünde, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Bünde at a glance
618
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

618 trials in Bünde

Open in trial search

Efficacy and Safety Evaluation of Odevixibat in Pediatric Biliary Atresia Post-Kasai Hepatoportoenterostomy: A Double-Blind, Randomized, Placebo-Controlled Trial

Investigational
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Odevixibat
  • Sponsor:Ipsen Pharma

A study to evaluate how the body processes zipalertinib in healthy adult men

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:[14C]ZIPALERTINIB
  • Sponsor:Taiho Oncology Inc.

Psoriasis

Not recruiting

A study to examine how the body processes and removes DC-806 in healthy male volunteers

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:DC-806
  • Sponsor:DICE Therapeutics Inc.

Drug level

Not recruiting

Study of BI 1810631 (C‑14) oral solution, BI 1810631 (C‑14) IV microtracer, and BI 1810631 tablet to assess absorption and metabolism in healthy men

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:BI 1810631 (C-14)
  • Sponsor:Boehringer Ingelheim International GmbH

Parkinson's disease

Not recruiting

Safety and Tolerability of NT-0796, Nadroparin, and Lidocaine Hydrochloride in Healthy Volunteers and Patients with Parkinson’s Disease

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Nadroparin Calcium
  • Sponsor:Nodthera Limited

Short-bowel syndrome

Not recruiting

Relative Bioavailability of Apraglutide in Prefilled Syringe versus Vial after Subcutaneous Injection in Healthy Subjects

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Apraglutide
  • Sponsor:VectivBio AG

Drug level

Not recruiting

Study of BI 1291583 oral tablets (1 mg and 5 mg) and intravenous microtracer in healthy male volunteers

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim International GmbH

Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Drug level

Not recruiting

Pharmacokinetic Study of BI 764198 XX (C‑14) and [4-(6‑aminopyridazin‑3‑yl)piperidin‑1‑yl][5-(4‑fluorophenoxy)-4‑methoxypyridin‑2‑yl]methanone in Healthy Men

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Apecotrep
  • Sponsor:Boehringer Ingelheim International GmbH

Multiple sclerosis+1

Not recruiting

Phase 1 study of remibrutinib exposure in cerebrospinal fluid after oral dosing in healthy participants

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:RO7268489
  • Sponsor:F. Hoffmann-La Roche AG

Autoimmune disorder

Not recruiting

Safety and Pharmacokinetics of Oral PTC844 in Healthy Participants for Autoimmune Disorder Treatment

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:PTC844
  • Sponsor:PTC Therapeutics Inc.

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Bünde

What the registry says about research in the country

01 Nutritional and Metabolic Diseases

The clinical trial activity in Bünde is centered on Nutritional and Metabolic Diseases, with studies focused on improving care for obesity, overweight, and type 2 diabetes. These trials are mainly testing new treatment approaches and assessing how well they support weight management and blood sugar control.

  • Weight-related treatment studies in obesity and overweight
  • Type 2 diabetes research aimed at better glycaemic control
  • Trials exploring therapy effectiveness in people with combined metabolic conditions
  • Clinical research designed to improve everyday treatment options

Several studies also connect metabolic health with other conditions, showing a broad interest in practical treatment strategies for patients in routine care.

02 Kidney Disease Research

One important area of research in Bünde involves chronic kidney disease, with trials examining whether new treatment combinations can help preserve kidney function. The goal is to evaluate treatment effectiveness and support better long-term kidney health.

  • Chronic kidney disease as a key focus of ongoing research
  • Studies assessing kidney function outcomes
  • Testing new therapeutic combinations for improved disease control

This work reflects a strong interest in finding more effective options for people living with progressive kidney problems.

03 Obesity and Weight Management

Clinical trials in the area of obesity and overweight are exploring whether new therapies can support meaningful body weight reduction. These studies are aimed at evaluating treatment benefit in people who need better options for long-term weight control.

  • Obesity and overweight as main conditions under study
  • Research focused on weight change and treatment response
  • Testing new approaches for healthier metabolic outcomes

The trials address an important area of public health by looking for more effective ways to manage excess weight.

04 Metabolic Disease and Diabetes Care

Another major theme is type 2 diabetes management, where trials are comparing treatment approaches to see how well they maintain blood sugar levels in real-world practice. The emphasis is on improving treatment effectiveness for people who already use glucose-lowering medication.

  • Type 2 diabetes treatment optimization
  • Comparisons of longer-acting and daily insulin-based options
  • Focus on sustained blood sugar control over time

These studies may help shape more practical and patient-friendly diabetes care strategies.

05 Osteoarthritis and Joint Pain

Research also includes osteoarthritis, especially knee pain linked with obesity or overweight. The trials are looking at ways to ease joint symptoms while also supporting weight-related health goals.

  • Osteoarthritis with a focus on knee pain
  • Studies involving people with obesity or overweight
  • Evaluation of symptom relief and functional improvement

This area connects musculoskeletal care with metabolic health, reflecting the close relationship between body weight and joint discomfort.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.